Lipocine Inc (NASDAQ:LPCN) Stock Attempts To Recover: Now What?
This past week the biopharmaceutical company Lipocine Inc (NASDAQ:LPCN) was in focus among investors after it announced its financial results for the second fiscal quarter of 2021 that ended on June 30. The financial results were announced this past Thursday but it was yesterday that the Lipocine stock moved and went up by 3%. In this situation, it could be a good idea for investors to take a closer look…